AbbVie Inc. is 110.4x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($399.47 B vs $3.62 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRNX | ABBV |
|---|---|---|
| Market cap | $3.62 B | $399.47 B |
| US-listed rank | #1659 | #28 |
| Revenue (latest FY) | $7.70M | $61.16B |
| Net income (latest FY) | -$465.30M | $4.23B |
| Net margin | -6046.0% | 6.9% |
| P/E (trailing FY) | - | 94.5 |
| SEC filings | 670 | 1,008 |
AbbVie Inc. is 110.4x more valuable than Crinetics Pharmaceuticals, Inc. by market capitalization ($399.47 B vs $3.62 B).
In their latest fiscal years, Crinetics Pharmaceuticals, Inc. reported $7.70M in revenue while AbbVie Inc. reported $61.16B.
Full pages: Crinetics Pharmaceuticals, Inc. and AbbVie Inc., or browse the full rankings.